Prospective Multicentre Non-Interventional Study to Assess the Patterns of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Follitropin delta (Primary)
- Indications Ovarian disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms PROFILE
- Sponsors Ferring Pharmaceuticals
- 02 Mar 2018 Status changed from not yet recruiting to recruiting.
- 12 Feb 2018 Planned initiation date changed from 31 Jan 2018 to 1 Mar 2018.
- 11 Jan 2018 New trial record